Iovance Biotherapeutics
Cindy Greysen has held various leadership roles in the field of medical affairs, working for companies such as Iovance Biotherapeutics, Immunocore, Genentech, Amgen, and InterMune. With a PharmD from the University of California, San Francisco, and a Bachelor of Science in Biochemistry from California Polytechnic State University-San Luis Obispo, Cindy has a strong educational background to support their career in the pharmaceutical industry.
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.